Enter the first few characters of Company and click 'Go'

Audited Results of Alembic Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Operating Income	5,149	5,035.41	5,051.44	4,132.55	3,660.27
Manufacturing Expenses	182.21	120.50	109.79	97.43	88.44
Personnel Expenses	1,094.82	1,062.30	948.27	806.37	684.45
Selling Expenses	0	0	0	0	342.47
Administrative Expenses	1,285.19	1,185.46	893.09	751.88	488.76
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	4,484.65	4,126.61	3,479.21	2,929.65	2,781.60
Operating Profit	664.35	908.80	1,572.23	1,202.90	878.67
Other Recurring Income	3.54	51.14	9.73	134.75	6.42
Adjusted PBDIT	667.89	959.94	1,581.96	1,337.65	885.09
Financial Expenses	49	17.02	12.77	25.19	14.87
Depreciation	272.95	284.92	152.60	135.67	105.59
Other Write offs	0	0	0	0	0
Adjusted PBT	345.94	658	1,416.59	1,176.79	764.63
Tax Charges	-0.79	114.45	241.20	197.39	153.42
Adjusted PAT	346.73	543.55	1,175.39	979.40	611.21
Non Recurring Items	0	0	-0.88	-19.33	-1.90
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	346.73	543.55	1,175.39	969.40	611.21
Equity Dividend	196.56	275.19	0	258.43	59.91
Preference Dividend	0	0	0	0	0
Retained Earnings	2,783.05	2,632.89	2,863.44	1,964.36	1,453.66

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article